Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gentamicin vs Streptomycin for Plague
NCT00128466Phase 3Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Aug 2004
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of gentamicin in plague (2 arms), sponsored by Centers for Disease Control and Prevention. Primary endpoint: Survival or death at 2 weeks. Started Aug 2004; status: completed.
02
Drugs
gentamicin
03
Conditions
plague
Beyond the preview
Go deeper on NCT00128466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00128466.